No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs565767321 |
chr2:97559926-97559927 |
Weak transcription Enhancers Bivalent Enhancer Transcr. at gene 5' and 3'
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
2 |
rs374140903 |
chr2:97559946-97559947 |
Weak transcription Enhancers Bivalent Enhancer Transcr. at gene 5' and 3'
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs528275707 |
chr2:97559984-97559985 |
Weak transcription Enhancers Bivalent Enhancer Transcr. at gene 5' and 3'
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs551253594 |
chr2:97560022-97560023 |
Weak transcription Enhancers Active TSS
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs571430629 |
chr2:97560031-97560032 |
Weak transcription Enhancers Active TSS
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs537100486 |
chr2:97560034-97560035 |
Weak transcription Enhancers Active TSS
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs556976624 |
chr2:97560057-97560058 |
Weak transcription Enhancers Active TSS
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs551229029 |
chr2:97560059-97560060 |
Weak transcription Enhancers Active TSS
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs57675226 |
chr2:97560137-97560138 |
Weak transcription Enhancers Active TSS
|
Chromatin interactive region
|
2 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
10 |
rs111608917 |
chr2:97560157-97560158 |
Weak transcription Enhancers Active TSS
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs186552734 |
chr2:97560164-97560165 |
Weak transcription Enhancers Active TSS
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs150671924 |
chr2:97560230-97560231 |
Weak transcription Enhancers Active TSS
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs553613273 |
chr2:97560234-97560235 |
Weak transcription Enhancers Active TSS
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs139857959 |
chr2:97560263-97560264 |
Weak transcription Enhancers Active TSS
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs191328602 |
chr2:97560402-97560403 |
Weak transcription Enhancers Active TSS
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs57632006 |
chr2:97560450-97560451 |
Weak transcription Enhancers Active TSS
|
Chromatin interactive region
|
2 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
17 |
rs183843349 |
chr2:97560490-97560491 |
Weak transcription Enhancers Active TSS
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
mRNA abundance
|
18 |
rs558098103 |
chr2:97560573-97560574 |
Weak transcription Enhancers Active TSS
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
19 |
rs568482485 |
chr2:97560625-97560626 |
Weak transcription Enhancers Flanking Active TSS
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs13421275 |
chr2:97560629-97560630 |
Weak transcription Enhancers Flanking Active TSS
|
Chromatin interactive region
|
2 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
21 |
rs368042394 |
chr2:97560661-97560662 |
Weak transcription Enhancers Flanking Active TSS
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs371962076 |
chr2:97560678-97560679 |
Weak transcription Enhancers Flanking Active TSS
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
23 |
rs577818919 |
chr2:97560684-97560685 |
Weak transcription Enhancers Flanking Active TSS
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs375861410 |
chr2:97560703-97560704 |
Weak transcription Enhancers Flanking Active TSS
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
25 |
rs80341479 |
chr2:97560801-97560802 |
Enhancers Weak transcription Flanking Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
26 |
rs563321472 |
chr2:97560812-97560813 |
Enhancers Weak transcription Flanking Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
27 |
rs372669788 |
chr2:97560834-97560835 |
Enhancers Weak transcription Flanking Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs542591597 |
chr2:97560842-97560843 |
Enhancers Weak transcription Flanking Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
29 |
rs559616510 |
chr2:97560869-97560870 |
Enhancers Weak transcription Flanking Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
30 |
rs189208296 |
chr2:97560909-97560910 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
31 |
rs4907206 |
chr2:97560913-97560914 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
32 |
rs192869401 |
chr2:97560944-97560945 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
33 |
rs79049408 |
chr2:97560962-97560963 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
34 |
rs551556680 |
chr2:97561031-97561032 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
35 |
rs144834340 |
chr2:97561075-97561076 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
36 |
rs185388521 |
chr2:97561083-97561084 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs550638729 |
chr2:97561100-97561101 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs529549762 |
chr2:97561106-97561107 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
39 |
rs541618670 |
chr2:97561107-97561108 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
40 |
rs140344512 |
chr2:97561144-97561145 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
41 |
rs536663569 |
chr2:97561145-97561146 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs546648633 |
chr2:97561147-97561148 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
43 |
rs537910000 |
chr2:97561204-97561205 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs144212173 |
chr2:97561218-97561219 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs147762702 |
chr2:97561254-97561255 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs575909683 |
chr2:97561293-97561294 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|